Trusted News Discovery Since 2008
{{/content}}
Itolizumab
Chemical compound
Itolizumab is a ‘first in class’ humanized IgG1 monoclonal antibody developed by Biocon and the Center of Molecular Immunology (CIM), Havana.
Itolizumab News and Videos LIVE
ℹ️ This is a LIVE page which updates automatically as we're monitoring our hand-curated selection of verified and trustworthy media outlets